PDCD1 and neoplasm: Though PD-1 expression has not always been associated with the exhausted T cell phenotype,45 our results suggest that exhausted T cells and their ligand-expressing immunosuppressive cells are present within the treated tumors and thus, addition of checkpoint inhibitors to this treatment should further enhance the anti-tumor response.